Chins Profile picture
Jul 9, 2022 17 tweets 6 min read Read on X
Deepak Nitrite has become a market darling over the last years, but how much do you know about its sister company?

Despite the name, only 10% of Deepak Fertilizer's profits come from fertilizers.

A short thread on why the company is actually a proxy play on infra.

1/14
In this thread:

• Why Deepak Fert is an explosives company.

• Competitive landscape.

• Why they've taken on two enormous capex projects.

• Antithesis pointers.

Disclosure: invested from lower levels, no transactions in 6 months.

2/14
With any company, it's important to understand the value chain and business segments first.

To those reading that find chemical names hard to remember, an easy way is to associate an end use with the chemical, and you'll never forget.

In this case, our focus is on TAN.

3/14
In FY22, TAN formed nearly 60% of the chemical revenues, and had the highest realisations.

Following this, nitric acid contributed 22% of the chemical revenues, and IPA is the least interesting part of the pie.

Sharing last year's revenue mix (image)

4/14
TAN is the biggest piece of this story, and makes or breaks Deepak Fertiliser's bottom line.

Coal and limestone mining companies use TAN to make explosives. They blast these mines prior to excavation.

DFPCL's management explains their value proposition (image).

5/14
So why is this interesting?

• While ultimately mining is a sunset sector, demand for coal and cement will remain for another 20 years.

• All of Deepak Fertilizer's competitors are PSUs!

6/14
Deepak Fert has planned to spend 𝟔𝟓𝟎𝟎 𝐂𝐫. on capacity expansion.

The first of DFPCL's large projects is ammonia. This is what they use to make TAN.

100% of the 500,000 tonnes will be consumed in house, and poses no sales risk.

7/14
What would the capacity coming online do to the PnL?

Sheet below contains calculations based on long term average prices of commodities. One can listen to Q3's concall for these figures and compute.

There are additional benefits the company gets that can add on 150 Cr.

8/14
The second capex plan is topline accretive. They're expanding TAN capacities, and building a new plant close to the mining hubs of India on the east.

India is a net importer of TAN, and this is an import substitute.

Image below has the TAN landscape over the next 5 years.

9/14
• TAN comes in three different grades. DFPCL is the only producer of all three grades, while competitors produce a single form.

• It remains to be seen whether competitors can stick to timelines.

In addition, management points out three things about the landscape:

10/14
When they first announced these plans, the amount of debt needed for these projects was a concern.

However, not all debt is the same, and should be broken up into short term and long term.

Due to a strong FY22, there is no more short term debt owed.

11/14
Antithesis pointers:

• End industries are cyclical. Realisations will depend on coal and cement outlook.

• TAN has elements to it that are commodity, and downstream elements that are not. May continue to trade at commodity valuations.

12/14
• Competitors are moving into TAN in 2025 if they can stick to timescales, and it will be a test of whether the different grades, in-house ammonia manufacturing, and strategic geography makes DFPCL a preferred customer.

• TAN realisations will likely soften in FY23.

13/14
The fertilizer division is also very interesting, and is a great case study of why turnarounds are slow.

Will write a Part II to cover the fertilizer business.

14/14
I hope you found this introduction useful.

Please consider re-tweeting the first tweet below.

For those interested, long read with more details at: forum.valuepickr.com/t/deepak-ferti…
Edit: I didn't expect it to be a controversial statement.

The extent of the relation between Deepak Nitrite and Fertilizer is in shared origins, with Mr. CK Mehta founding both companies. There is no other relation between the two.

Old article from 2003: timesofindia.indiatimes.com/business/india…
On the pledge: a large portion of it is an NDU, and not really a pledge. Actual percentage of holding pledged is 6.94%, and has been steadily falling in the last year.

This is not a buy recommendation, merely a discussion on one vertical of the business.

• • •

Missing some Tweet in this thread? You can try to force a refresh
 

Keep Current with Chins

Chins Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!

PDF

Twitter may remove this content at anytime! Save it as PDF for later use!

Try unrolling a thread yourself!

how to unroll video
  1. Follow @ThreadReaderApp to mention us!

  2. From a Twitter thread mention us with a keyword "unroll"
@threadreaderapp unroll

Practice here first or read more on our help page!

More from @Chins1729

Dec 9, 2023
There is a potential trigger for the Indian shrimp sector looming in the next year.

The United States is considering import duties on four countries: India, Ecuador, Indonesia and Vietnam.

The fine print is extremely important, and could mark an end to the downcycle.

A thread. Image
Background:

Ecuador has undercut the market significantly, selling shrimp 15-20% cheaper than India. This has allowed them to gain a significant market share in shrimp over the last two years.

(See multiple posts from @theHarshFolio and @Tijori1 highlighting this)

2/z Image
The undercutting and subsequent price erosion has destroyed the margins of domestic shrimp producers in the US. Out of a market of around 1.7 million pounds (Freedom Units), the domestic producers make around 200k pounds of shrimp.

3/z Image
Read 17 tweets
Feb 18, 2023
Caplin Steriles is just simple enough to provide a case study on what an injectables portfolio looks like.

Insights like these are often in expensive market research reports, but I think it's better shared publicly.

Here's a data backed look into their growth strategy.

1/11
Caplin Point invested in their injectable plant in 2014, and launched their first molecule Ketorolac, around 2018.

Their strategy is to sell B2B to US pharma businesses.

Ketorolac is quite a large molecule, at $25 million, and Gland controls almost all of the market share.

2/
Since going commercial, Caplin has managed to scale Ketorolac at a CAGR of around 20%, and now captures around 15% of the market share.

Following this, they started filing ANDAs in other molecules. What do you see in common in all of these?

3/
Read 12 tweets
Aug 27, 2022
I had a conversation with the founder of PropEquity last week.

Companies listed on the SME index often have little to no information about them, and almost everything is found through scuttlebutt.

A window into the business, and the nascent Prop Tech industry.

1/ Image
PropEquity's main offering is a data analytics database that captures nuanced granular information on the real estate market.

Example below:

2/ Image
On a customizable scale across 44 cities, they offer information on supply, demand, pricing and vacancies.

This helps developers, banks, real estate companies, etc. understand the market landscape.

3/ ImageImage
Read 20 tweets
Aug 1, 2022
On Deepak Fert's concall. Focus is now on better end use for products.

• Solar / steel grade nitric acid.

• Medical wipes for IPA.

• Total cost of operations for entire mines, not just TAN.

Q2 will be a soft quarter seasonally. No guidance for H2, depends on spreads.

1/
On the 500 Cr. tax question, is a particular change in norms for depreciation / goodwill.

They believe it is entirely legal based on precedent in courts, and are prepared.

At worst case, will need a 20% deposit of around 110 Cr. before it's heard in court.

2/
Debt position is better than last quarter.

Q4FY22: Spent 2450 Cr. on ammonia, gross debt of 2500 Cr., net debt of 1800 Cr.

Q1FY23: Spent 2850 Cr. on ammonia, gross debt of 2900 Cr., net debt of 1930 Cr.

Only 130 Cr. higher debt despite spending 400 Cr. more on capex.

3/
Read 4 tweets
Jul 31, 2022
Currently studying a company that has numbers so ugly on Screener that not many will look further.

At 1.3x sales, I find the valuations very attractive for a luxury brand retailer, with an e-commerce platform to boot.

A high level introduction to Arvind Fashions.

1/
Disclaimer:

I'm not invested in this company, but I'm evaluating the opportunity.

Summary:
• Presence in very strong premium brands.
• Encouraging traction in e-commerce website, and focus on D2C.
• Cheap starting valuations, and improving return metrics.

2/
Arvind Fashions is owned by the Lalbhai dynasty from Ahmedabad, and this particular company was born out of succession planning.

forbes.com/sites/anuraghu…

We're talking about the branded garments business, headed by Mr. Kulin Lalbhai.

3/
Read 15 tweets
Jul 30, 2022
Don't let FOMO drive your investment decisions.

A short thread on the volatility behind Deepak Fert's amazing results.

1/
The star of this show is Technical Ammonium Nitrate, which probably contributed more than 60% of the profits this quarter.

To show you just how cyclical this is, I present two data points on prices. One on general ammonium nitrate prices in the UK, and one on TAN from IIFL.

2/
So prices are well above historic averages. For these reasons, one should really be careful in annualising Deepak's Q1 result.

How will the rest of the year look? No one can tell you from now how long prices will sustain, and how sharply they'll revert to the mean.

3/
Read 11 tweets

Did Thread Reader help you today?

Support us! We are indie developers!


This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3/month or $30/year) and get exclusive features!

Become Premium

Don't want to be a Premium member but still want to support us?

Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal

Or Donate anonymously using crypto!

Ethereum

0xfe58350B80634f60Fa6Dc149a72b4DFbc17D341E copy

Bitcoin

3ATGMxNzCUFzxpMCHL5sWSt4DVtS8UqXpi copy

Thank you for your support!

Follow Us!

:(